Effect of non-persistent use of oral glucose-lowering drugs on HbA_1c goal attainment

References

• WHO. Diabetes mellitus. In: WHO Media Centre; 2006.1WHO. Diabetes mellitus. In: WHO Media Centre; 2006.
   Google Scholar
• Selvin E, Marinopoulos S, Berkenblit G. et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421–312Selvin E, Marinopoulos S, Berkenblit G. et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421–31
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321:405–123Stratton IM, Adler AI, Neil HA. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321:405–12
   PubMed Web of Science ®Google Scholar
• Ryden L, Standl E, Bartnik M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. [The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Stydy of Diabetes (EASD)]. Eur Heart J 2007;28:88–1364Ryden L, Standl E, Bartnik M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. [The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Stydy of Diabetes (EASD)]. Eur Heart J 2007;28:88–136
   PubMed Web of Science ®Google Scholar
• Rutten GEHM, De Grauw WJC, Nijpels G. et al. NHG-Standard Diabetes mellitus type 2 (tweede herziening) NHG Practice Guideline Diabetes Mellitus Type 2, 2nd revision. Huisarts Wet 2006;49:137–525Rutten GEHM, De Grauw WJC, Nijpels G. et al. NHG-Standard Diabetes mellitus type 2 (tweede herziening) NHG Practice Guideline Diabetes Mellitus Type 2, 2nd revision. Huisarts Wet 2006;49:137–52
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2006. Diabetes Care 2006;29 Suppl 1:S4–S426American Diabetes Association. Standards of medical care in diabetes – 2006. Diabetes Care 2006;29 Suppl 1:S4–S42
   PubMedGoogle Scholar
• Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004;291:335–427Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004;291:335–42
   PubMed Web of Science ®Google Scholar
• Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002;45:S23–S288Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002;45:S23–S28
   PubMed Web of Science ®Google Scholar
• Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007;33:1014–299Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007;33:1014–29
   PubMed Web of Science ®Google Scholar
• Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218–2410Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218–24
   PubMed Web of Science ®Google Scholar
• Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care 2004;10:144–5111Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care 2004;10:144–51
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA. et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166:1836–4112Ho PM, Rumsfeld JS, Masoudi FA. et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166:1836–41
   PubMed Web of Science ®Google Scholar
• Lawrence DB, Ragucci KR, Long LB. et al. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006;12:466–7113Lawrence DB, Ragucci KR, Long LB. et al. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006;12:466–71
   PubMed Web of Science ®Google Scholar
• Pladevall M, Williams LK, Potts LA. et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800–514Pladevall M, Williams LK, Potts LA. et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800–5
   PubMed Web of Science ®Google Scholar
• Lau DT, Nau DP. Oral antihyperglycemic medication non-adherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27:2149–5315Lau DT, Nau DP. Oral antihyperglycemic medication non-adherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27:2149–53
   PubMed Web of Science ®Google Scholar
• Catalan VS, Lelorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2000;3:417–2616Catalan VS, Lelorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2000;3:417–26
   PubMedGoogle Scholar
• Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015–2117Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015–21
   PubMed Web of Science ®Google Scholar
• Riedel AA, Heien H, Wogen J, Plauschinat CA. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy 2007;27:1102–1018Riedel AA, Heien H, Wogen J, Plauschinat CA. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy 2007;27:1102–10
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB. et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29:1963–7219Nathan DM, Buse JB, Davidson MB. et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29:1963–72
   PubMed Web of Science ®Google Scholar